Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation

Published:2018-05 Issue:5 Volume:24 Page:909-913
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bhella Sita,Majhail Navneet S.,Betcher Jeffrey,Costa Luciano J.,Daly Andrew,Dandoy Christopher E.,DeFilipp Zachariah,Doan Vi,Gulbis Alison,Hicks Lisa,Juckett Mark,Khera Nandita,Krishnan Amrita,Selby George,Shah Nirav N.,Stricherz Melisa,Viswabandya Auro,Bredeson Christopher,Seftel Matthew D.

Funder

ASBMT,

CBMTG

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference40 articles.

1. Engaging patients and the public in Choosing Wisely;Born;BMJ Qual Saf,2017

2. The ASH Choosing Wisely(R) campaign: five hematologic tests and treatments to question;Hicks;Blood,2013

3. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia;Schrezenmeier;Blood,2007

4. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party;Bacigalupo;Haematologica,2010

5. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups;Bacigalupo;Haematologica,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IgG replacement in multiple myeloma;Blood Cancer Journal;2024-07-25

2. Strategic infection prevention after genetically modified hematopoietic stem cell therapies: recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee;Cytotherapy;2024-07

3. Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies;Transplantation and Cellular Therapy;2024-07

4. Hematopoietic Cell Collection;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

5. Rituximab for posttransplant lymphoproliferative disorder – therapeutic, preemptive, or prophylactic?;Bone Marrow Transplantation;2023-11-25